tiprankstipranks
Trending News
More News >
Cohort PLC (GB:CHRT)
LSE:CHRT

Cohort plc (CHRT) AI Stock Analysis

Compare
69 Followers

Top Page

GB:CHRT

Cohort plc

(LSE:CHRT)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 5.2)
Rating:69Neutral
Price Target:
1,416.00p
▲(49.21% Upside)
Action:ReiteratedDate:12/07/25
Cohort plc's strong financial performance and positive corporate events are offset by bearish technical indicators and moderate valuation. The company's robust revenue growth and strategic management actions provide a solid foundation, but current market sentiment suggests caution.
Positive Factors
Strong Revenue Growth
Sustained ~19% revenue growth demonstrates durable demand and successful contract wins in defense and aerospace. For a business reliant on long-term government and commercial contracts, this trend supports predictable backlog conversion, capacity utilization, and strategic reinvestment over the next 2–6 months.
Conservative Leverage
A 0.50 debt-to-equity and 40% equity ratio signal a conservative capital structure that preserves financial flexibility. This reduces refinancing risk, supports bidding on multi-year contracts, and allows management to pursue organic investment or selective M&A without overleveraging the business.
Strong Operating Cash Generation
Operating cash flow ~2.66x net income indicates robust cash conversion from core operations, important for funding working capital on long-term contracts and supporting R&D or technology investment. This durable cash strength underpins balance sheet resilience and operational continuity.
Negative Factors
Weak FCF Conversion
Free cash flow conversion below 1.0 suggests a sizable portion of accounting earnings isn't translating to discretionary cash. Over months, this can limit capital allocation flexibility, slow debt paydown or dividend growth, and constrain funding for new product development or larger contract performance needs.
Pressure on Margins
Evidence of falling gross and operating margins points to cost inflation or competitive pricing pressure. For a specialist defense supplier, margin erosion reduces the cushion for fixed overheads and R&D, making earnings more sensitive to contract mix and bid competitiveness over the medium term.
Declining EPS Trend
Negative EPS growth near -15% signals deterioration in per-share earnings, which may reflect margin pressure, non-recurring items, or dilution. Persisting EPS decline undermines reinvestment capacity and investor confidence, and can limit strategic options if not reversed within coming quarters.

Cohort plc (CHRT) vs. iShares MSCI United Kingdom ETF (EWC)

Cohort plc Business Overview & Revenue Model

Company DescriptionCohort plc, through its subsidiaries, provides various products and services in defense and security markets in the United Kingdom, Germany, Portugal, Africa, North and South America, and other European countries. The company offers electro-optical and electro-mechanical systems, such as command, control, communications, computers, intelligence, surveillance, target acquisition, and reconnaissance, as well as combat systems; and communications systems. It also provides integrated command, control, and communications systems for warships and submarines; tactical radio, vehicle intercoms, field communications, and networking software and equipment; electronic warfare operational support, managed, secure communications, cyber security, and training support services; and electronic and surveillance technology services. In addition, the company offers training and simulation; digital forensics; and research, advice, and support services. It provides products and services for customers in the defense and security markets for land, maritime, and air applications, as well as civil markets covering the security, transport, and the oil and gas industry. Cohort plc was incorporated in 2006 and is headquartered in Reading, the United Kingdom.
How the Company Makes MoneyCohort plc generates revenue primarily through the provision of specialized engineering and technology services, often under long-term contracts with government and defense agencies. The company's key revenue streams include software development, systems integration projects, and consultancy services. Additionally, Cohort benefits from partnerships with defense organizations and technology providers, which can lead to joint contracts and collaborative projects. The company also sees revenue from the sale of proprietary technology products and intellectual property, further diversifying its income sources.

Cohort plc Financial Statement Overview

Summary
Cohort plc exhibits strong revenue growth and stable profitability, supported by a solid balance sheet with conservative leverage. While cash flow generation is positive, the company should focus on improving free cash flow conversion to support future growth initiatives.
Income Statement
82
Very Positive
Cohort plc has demonstrated strong revenue growth with a 19.24% increase in the latest year, indicating robust demand and effective market positioning. The gross profit margin has slightly decreased, but remains healthy at 33.49%. Net profit margin is stable at 7.13%, reflecting consistent profitability. However, the slight decline in EBIT and EBITDA margins suggests potential cost pressures or increased competition.
Balance Sheet
78
Positive
The company's debt-to-equity ratio of 0.50 indicates a conservative leverage approach, enhancing financial stability. Return on equity is solid at 12.14%, showcasing effective use of shareholder funds. The equity ratio of 40.00% suggests a strong capital structure, though there is room for improvement in asset utilization.
Cash Flow
75
Positive
Cohort plc's free cash flow growth of 3.20% is modest, but positive, indicating effective cash management. The operating cash flow to net income ratio of 2.66 suggests strong cash generation relative to earnings. However, the free cash flow to net income ratio of 0.74 indicates potential constraints in free cash flow relative to net income, which could impact future investments.
BreakdownTTMApr 2024Apr 2023Apr 2022Apr 2021Apr 2020
Income Statement
Total Revenue280.62M270.04M202.53M182.71M137.76M143.31M
Gross Profit79.19M90.42M76.27M64.86M56.60M53.36M
EBITDA34.40M35.57M29.25M23.07M21.79M21.36M
Net Income18.26M19.25M15.32M11.36M9.20M5.46M
Balance Sheet
Total Assets413.94M396.58M252.50M210.69M203.17M190.88M
Cash, Cash Equivalents and Short-Term Investments53.16M74.65M55.16M41.45M40.37M32.29M
Total Debt95.13M78.88M40.51M34.98M39.52M37.38M
Total Liabilities247.03M236.49M142.66M110.91M113.98M105.83M
Stockholders Equity165.48M158.61M108.67M97.02M83.97M79.31M
Cash Flow
Free Cash Flow-27.65M38.00M16.36M11.29M17.52M14.97M
Operating Cash Flow-10.79M51.18M23.02M16.52M19.52M16.22M
Investing Cash Flow-89.57M-93.65M-6.16M-6.11M-2.37M-2.54M
Financing Cash Flow69.18M46.18M-16.92M-10.57M-8.70M-1.55M

Cohort plc Technical Analysis

Technical Analysis Sentiment
Positive
Last Price949.00
Price Trends
50DMA
1101.80
Positive
100DMA
1149.72
Positive
200DMA
1283.38
Positive
Market Momentum
MACD
38.33
Negative
RSI
67.31
Neutral
STOCH
81.59
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CHRT, the sentiment is Positive. The current price of 949 is below the 20-day moving average (MA) of 1174.60, below the 50-day MA of 1101.80, and below the 200-day MA of 1283.38, indicating a bullish trend. The MACD of 38.33 indicates Negative momentum. The RSI at 67.31 is Neutral, neither overbought nor oversold. The STOCH value of 81.59 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:CHRT.

Cohort plc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
£2.98B63.145.21%1.27%0.84%-62.73%
71
Outperform
$61.59B30.7017.90%1.99%11.60%8.03%
69
Neutral
£593.77M31.5713.24%1.58%23.91%-14.66%
68
Neutral
£6.73B23.7246.10%0.56%7.36%48.93%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
63
Neutral
£1.44B30.0014.44%1.64%-2.53%22.25%
58
Neutral
£2.65B-13.252.00%-4.59%-256.51%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:CHRT
Cohort plc
1,292.00
124.33
10.65%
GB:BA
BAE Systems
2,112.00
531.05
33.59%
GB:BAB
Babcock International
1,352.00
646.33
91.59%
GB:CHG
Chemring
534.00
140.41
35.67%
GB:SRP
Serco Group plc
301.20
141.92
89.10%
GB:QQ
QinetiQ
505.00
56.82
12.68%

Cohort plc Corporate Events

Business Operations and StrategyRegulatory Filings and Compliance
Cohort updates share option plan block listing and highlights global defence tech footprint
Neutral
Feb 25, 2026

Cohort plc, an AIM-listed defence technology group based in Reading, Berkshire, operates seven specialist businesses in the U.K., Australia, Germany and Portugal. The group focuses on communications, intelligence, sensors and effectors, providing advanced systems such as naval communications, mobile satellite terminals, sonar, surveillance and electronic warfare solutions to defence and related markets.

The company has reported its latest six‑monthly block listing return for its Company Share Option Plan, showing that 133,918 shares were issued or allotted during the period from 25 August 2025 to 24 February 2026. Following these issuances, 1,405,162 securities remain available but unallotted under the scheme, indicating continued use of equity-based incentives while maintaining a substantial reserve for future employee and management share options.

The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1328.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.

Dividends
Cohort Directors Boost Stakes via Dividend Reinvestment
Positive
Feb 20, 2026

Cohort plc has disclosed that its chief executive, Andrew Thomis, and finance director, Simon Walther, have increased their holdings in the company through automatic reinvestment of interim dividend payments. Following these transactions, Thomis and his closely associated persons now hold 186,759 shares, or 0.40% of the company’s issued share capital, while Walther and his associated person hold 150,935 shares, representing 0.32%.

The dividend reinvestments, executed via Global Nominee, Share Incentive Plan and ISA accounts between 17 and 19 February on AIM, signal continued equity alignment of Cohort’s senior management with shareholders. Although the incremental share purchases are relatively small in volume, they modestly strengthen insider ownership and may be viewed by investors as a sign of management’s ongoing commitment to the group’s long-term prospects in the defence technology sector.

The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1331.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.

Executive/Board ChangesRegulatory Filings and Compliance
Cohort grants long-term share award to new chief operating officer
Neutral
Feb 16, 2026

Cohort plc has granted a restricted share award to its newly appointed Chief Operating Officer, Christopher Axcell, as part of its executive incentive arrangements. Axcell, who joined the group on 6 February 2026, received an award of 4,435 nil-cost ordinary shares under the Cohort Restricted Share Plan.

The shares are scheduled to vest no earlier than 13 February 2029, subject to Axcell’s continued employment with the Cohort group. The transaction, conducted outside a trading venue, was disclosed in line with EU Market Abuse Regulation requirements, underlining the company’s adherence to governance and transparency standards around senior management remuneration.

The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1249.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.

Regulatory Filings and Compliance
Cohort Updates Total Voting Rights Following Share Capital Review
Neutral
Feb 2, 2026

Cohort plc has reported that, as at 31 January 2026, its issued share capital comprised 46,983,433 ordinary shares of 10 pence each, all carrying one vote per share, with no shares held in treasury. This updated total voting rights figure serves as the new reference denominator for investors assessing whether they must disclose holdings or changes in interests under UK transparency rules, providing clarity for shareholders and reinforcing the company’s compliance with market disclosure requirements.

The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1249.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Cohort’s MCL Lands £17.9m UK Defence Orders, Securing 2025/26 Revenue Targets
Positive
Jan 30, 2026

Cohort plc has announced that its subsidiary Marlborough Communications Ltd (MCL) has secured new UK defence contracts worth a combined £17.9m, including a £14.0m award from a UK government customer for immediate delivery of uncrewed air systems with two years of in-service support, in partnership with long-term supplier Skydio. MCL has also received a £3.9m order for tactical audio systems from a UK customer, with Cohort chief executive Andrew Thomis saying the wins underline MCL’s strong customer relationships and engineering capability, strengthen the Group’s order book and revenue visibility, and fully underpin consensus revenue forecasts for the 2025/26 financial year.

The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1249.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Cohort Publishes Interim Report for Six Months to 31 October 2025
Neutral
Jan 15, 2026

Cohort plc has published its interim report for the six months to 31 October 2025, making the document available to shareholders via post or online through its investor relations website. The release underscores the company’s ongoing disclosure to the market as it integrates its diversified defence technology portfolio, including the recently acquired EM Solutions, and maintains its positioning as a specialist provider of communications, intelligence, sensor and effector systems to defence customers worldwide.

The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1190.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Cohort to Present Half-Year Results and Strategy in Live Investor Webinar
Positive
Jan 5, 2026

Cohort plc has announced that its Chief Executive, Andrew Thomis, and Finance Director, Simon Walther, will deliver a live investor presentation via Equity Development on 14 January 2026, where they will discuss the company’s recent half-year results and outline its corporate strategy. The webinar, which is free and open to both existing and potential shareholders, will include a Q&A session and be recorded for later viewing, underscoring Cohort’s efforts to enhance transparency and engage more directly with investors as it continues to develop its position in the international defence technology market.

The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1190.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.

Regulatory Filings and Compliance
Cohort Updates Market on Total Voting Rights and Share Capital
Neutral
Jan 2, 2026

Cohort plc has confirmed that as at 31 December 2025 its issued share capital comprised 46,950,593 ordinary shares of 10 pence each, with each share carrying one voting right and no shares held in treasury. This updated total voting rights figure provides the basis for shareholders and investors to calculate whether they are required to disclose holdings or changes in their interests under UK market transparency rules, reinforcing regulatory clarity around the company’s capital structure.

The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1190.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Cohort to Brief Investors on Half-Year Results and Strategy via Live Online Presentation
Positive
Dec 22, 2025

Cohort plc has announced that its Chief Executive, Andrew Thomis, and Finance Director, Simon Walther, will host a live investor presentation on the Engage Investor platform on 12 January at 2:30pm GMT. During the session, they will discuss the group’s recent half-year results and outline its corporate strategy, with current shareholders and prospective investors invited to attend, follow the company via a personalised investor hub and submit questions before or during the event, underscoring Cohort’s efforts to enhance transparency and engagement with the investment community.

The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1190.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.

Regulatory Filings and Compliance
Cohort plc CEO Transfers Shares to Spouse
Neutral
Dec 15, 2025

Cohort plc announced that its Chief Executive, Andrew Thomis, transferred 80,000 ordinary shares to his spouse without any change in his beneficial interest, which remains at 186,600 shares, representing 0.40% of the company’s total issued share capital. This transaction, conducted on the London Stock Exchange AIM, is part of regulatory compliance and does not impact the company’s operations or market positioning.

The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1190.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.

Regulatory Filings and Compliance
Cohort plc Director Shareholding Update
Neutral
Dec 11, 2025

Cohort plc announced that Simon Walther, the Finance Director, transferred 75,000 ordinary shares to his spouse without any financial consideration, maintaining his beneficial interest in the company at 0.32% of the total issued share capital. This transaction, conducted outside of a Main Market, is in compliance with the EU Market Abuse Regulation, and does not alter the overall shareholding structure, reflecting a neutral impact on the company’s operations and market positioning.

The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1190.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.

Business Operations and StrategyDividendsFinancial Disclosures
Cohort plc Reports Revenue Growth and Strong Order Book in H1 2025
Positive
Dec 10, 2025

Cohort plc reported a 9% increase in revenue to £128.8 million for the first half of 2025, driven by contributions from EM Solutions and other group businesses, except MCL. Despite a slight decrease in adjusted operating profit to £9.7 million, the company maintained a strong order book of £604.5 million and increased its interim dividend by 10%, reflecting confidence in future growth. The Communications and Intelligence division saw a significant profit increase, while the Sensors and Effectors division experienced lower margins due to specific project contributions. The company expects improved performance in the second half of the year, supported by a robust order book and positive outlook for organic growth in core defence markets.

The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1190.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 07, 2025